Correlation Between Seres Therapeutics and Intercept Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Seres Therapeutics and Intercept Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seres Therapeutics and Intercept Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seres Therapeutics and Intercept Pharmaceuticals, you can compare the effects of market volatilities on Seres Therapeutics and Intercept Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seres Therapeutics with a short position of Intercept Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seres Therapeutics and Intercept Pharmaceuticals.
Diversification Opportunities for Seres Therapeutics and Intercept Pharmaceuticals
0.4 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Seres and Intercept is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Seres Therapeutics and Intercept Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intercept Pharmaceuticals and Seres Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seres Therapeutics are associated (or correlated) with Intercept Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intercept Pharmaceuticals has no effect on the direction of Seres Therapeutics i.e., Seres Therapeutics and Intercept Pharmaceuticals go up and down completely randomly.
Pair Corralation between Seres Therapeutics and Intercept Pharmaceuticals
If you would invest 70.00 in Seres Therapeutics on August 27, 2024 and sell it today you would earn a total of 7.00 from holding Seres Therapeutics or generate 10.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 4.76% |
Values | Daily Returns |
Seres Therapeutics vs. Intercept Pharmaceuticals
Performance |
Timeline |
Seres Therapeutics |
Intercept Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Seres Therapeutics and Intercept Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Seres Therapeutics and Intercept Pharmaceuticals
The main advantage of trading using opposite Seres Therapeutics and Intercept Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seres Therapeutics position performs unexpectedly, Intercept Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intercept Pharmaceuticals will offset losses from the drop in Intercept Pharmaceuticals' long position.Seres Therapeutics vs. Syros Pharmaceuticals | Seres Therapeutics vs. Iovance Biotherapeutics | Seres Therapeutics vs. Veracyte | Seres Therapeutics vs. Fate Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |